Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

11.1%

48 terminated/withdrawn out of 432 trials

Success Rate

72.1%

-14.4% vs industry average

Late-Stage Pipeline

18%

78 trials in Phase 3/4

Results Transparency

6%

7 of 124 completed trials have results

Key Signals

29 recruiting7 with results26 terminated22 withdrawn

Enrollment Performance

Analytics

N/A
182(56.3%)
Phase 4
50(15.5%)
Phase 2
36(11.1%)
Phase 3
28(8.7%)
Phase 1
23(7.1%)
Early Phase 1
4(1.2%)
323Total
N/A(182)
Phase 4(50)
Phase 2(36)
Phase 3(28)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (432)

Showing 20 of 432 trials
NCT03510078Not ApplicableCompleted

Intensive Versus Conventional Hyperglycemic Control in Hospitalized Non-critically Ill Patients

Role: lead

NCT07226089Phase 3Recruiting

Comparison of Weekly Somatrogon to Daily Genotropin in Children Born Small for Gestational Age or With Idiopathic Short Stature.

Role: lead

NCT03451968Not ApplicableRecruiting

Amino Acid Metabolism in Fed Surgical Critically Ill Patients

Role: lead

NCT07491874Not ApplicableNot Yet Recruiting

Use of Nitrous Oxide for Pain and Anxiety Management During Cervical Cerclage Removal

Role: collaborator

NCT05171725Completed

Multidisciplinary Expert System for the Assessment & Management of Complex Brain Disorders

Role: collaborator

NCT07362992Early Phase 1Not Yet Recruiting

Topical Tranexamic Acid to Reduce Blood Loss During Cesarean Delivery

Role: collaborator

NCT06837909Not ApplicableRecruiting

Transversus Abdominis Plane Block Versus Wound Infiltration for Pulmonary Function Preservation Following Laparoscopic Living Donor Nephrectomy

Role: lead

NCT06029244Not ApplicableCompleted

Eyecontrol coMmunication Platform for dEliRium manaGemEnt in Intensive Care Units (EMERGE)

Role: collaborator

NCT03774069Not ApplicableTerminated

The Advisor Pro Direct Study

Role: lead

NCT07208240Phase 1Recruiting

Tb-PSMA-I&T Radionuclide Before Radical Prostatectomy in Patients With Locally Advanced Prostate Cancer - TbeforePROST Trial.

Role: lead

NCT07173894Not ApplicableRecruiting

Effectiveness of Field Block Compared With Interscalene Block in Shoulder Surgery

Role: lead

NCT07131163Recruiting

Real World Stage II-III NSCLC Patients Receiving Neoadjuvant Chemo-immunotherapy and no Surgical Resection

Role: collaborator

NCT03671967Phase 4Recruiting

PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN)

Role: collaborator

NCT05627622Not ApplicableActive Not Recruiting

Effectiveness of WhatsApp Education and Support Messages for Urolithiasis Prevention

Role: lead

NCT05992363Not ApplicableRecruiting

Tandem Polyurethane Stents Compared to Single Silicone Stent for Malignant Ureteral Obstruction

Role: lead

NCT05355350Phase 4Withdrawn

PipEracillin/Tazobactam Versus mERoPENem for Treatment of AmpC Producing Blood Stream Infections

Role: collaborator

NCT06729502Recruiting

Pictorial Fit-Frail Scale in Adults Admitted to the ICU in a Tertiary Center- an Observational Prospective Study

Role: lead

NCT06951399Phase 2Not Yet Recruiting

Tracking T-Cell Responses to Evaluate Pembrolizumab Effectiveness in Advanced Non-Small Cell Lung Cancer

Role: lead

NCT02805023Phase 1Active Not Recruiting

BGC101 (EnEPC) Autologous Cell Therapy From Patient's Own Blood for Treatment of Critical Limb Ischemia (CLI)

Role: collaborator

NCT06779331Active Not Recruiting

Phosphate Urine Excretion in Critically Ill Patients

Role: lead